These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16893425)

  • 1. Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease.
    Kirvell SL; Esiri M; Francis PT
    J Neurochem; 2006 Aug; 98(3):939-50. PubMed ID: 16893425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
    Tannenberg RK; Scott HL; Tannenberg AE; Dodd PR
    Neurochem Int; 2006 Dec; 49(7):631-9. PubMed ID: 16814428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VGLUTs: 'exciting' times for glutamatergic research?
    Takamori S
    Neurosci Res; 2006 Aug; 55(4):343-51. PubMed ID: 16765470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.
    Kashani A; Lepicard E; Poirel O; Videau C; David JP; Fallet-Bianco C; Simon A; Delacourte A; Giros B; Epelbaum J; Betancur C; El Mestikawy S
    Neurobiol Aging; 2008 Nov; 29(11):1619-30. PubMed ID: 17531353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
    Uezato A; Meador-Woodruff JH; McCullumsmith RE
    Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1).
    Tordera RM; Totterdell S; Wojcik SM; Brose N; Elizalde N; Lasheras B; Del Rio J
    Eur J Neurosci; 2007 Jan; 25(1):281-90. PubMed ID: 17241289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
    Minkeviciene R; Ihalainen J; Malm T; Matilainen O; Keksa-Goldsteine V; Goldsteins G; Iivonen H; Leguit N; Glennon J; Koistinaho J; Banerjee P; Tanila H
    J Neurochem; 2008 May; 105(3):584-94. PubMed ID: 18042177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain site-specific gene expression analysis in Alzheimer's disease patients.
    Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
    Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamatergic systems in Alzheimer's disease.
    Francis PT
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S15-21. PubMed ID: 12973746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease.
    Scott HA; Gebhardt FM; Mitrovic AD; Vandenberg RJ; Dodd PR
    Neurobiol Aging; 2011 Mar; 32(3):553.e1-11. PubMed ID: 20416976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rose Bengal analogs and vesicular glutamate transporters (VGLUTs).
    Pietrancosta N; Kessler A; Favre-Besse FC; Triballeau N; Quentin T; Giros B; El Mestikawy S; Acher FC
    Bioorg Med Chem; 2010 Sep; 18(18):6922-33. PubMed ID: 20708942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal expression of vimentin in the Alzheimer's disease brain may be part of a generalized dendritic damage-response mechanism.
    Levin EC; Acharya NK; Sedeyn JC; Venkataraman V; D'Andrea MR; Wang HY; Nagele RG
    Brain Res; 2009 Nov; 1298():194-207. PubMed ID: 19728994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology.
    Julien C; Tremblay C; Bendjelloul F; Phivilay A; Coulombe MA; Emond V; Calon F
    J Neurosci Res; 2008 Aug; 86(10):2292-302. PubMed ID: 18338803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amyloid pathology progresses in a neurotransmitter-specific manner.
    Bell KF; Ducatenzeiler A; Ribeiro-da-Silva A; Duff K; Bennett DA; Cuello AC
    Neurobiol Aging; 2006 Nov; 27(11):1644-57. PubMed ID: 16271419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
    Kumar U; Patel SC
    Brain Res; 2007 Feb; 1131(1):187-96. PubMed ID: 17182012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synapse-specific localization of vesicular glutamate transporters in the rat olfactory bulb.
    Gabellec MM; Panzanelli P; Sassoè-Pognetto M; Lledo PM
    Eur J Neurosci; 2007 Mar; 25(5):1373-83. PubMed ID: 17425564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glutamate and Alzheimer's disease].
    Gazulla J; Cavero-Nagore M
    Rev Neurol; 2006 Apr 1-15; 42(7):427-32. PubMed ID: 16602060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic and vesicular co-localization of the glutamate transporters VGLUT1 and VGLUT2 in the mouse hippocampus.
    Herzog E; Takamori S; Jahn R; Brose N; Wojcik SM
    J Neurochem; 2006 Nov; 99(3):1011-8. PubMed ID: 16942593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's Disease-associated Region-specific Decrease of Vesicular Glutamate Transporter Immunoreactivity inthe Medial Temporal Lobe and Superior Temporal Gyrus.
    Wood OWG; Walby J; Yeung JH; Ke S; Palpagama TH; Turner C; Waldvogel HJ; Faull RLM; Kwakowsky A
    Neuroscience; 2024 May; 546():75-87. PubMed ID: 38552733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between neuronal loss and 'inflammatory plaques' in early onset Alzheimer's disease.
    Shepherd CE; Grace EM; Mann DM; Halliday GM
    Neuropathol Appl Neurobiol; 2007 Jun; 33(3):328-33. PubMed ID: 17493013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.